COMMUNIQUÉS West-GlobeNewswire

-
NÉOVACS : RÉSULTATS ANNUELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES
30/03/2018 - 07:31 -
MedMira Reports Second Quarter Results
30/03/2018 - 01:00 -
Scythian Biosciences Announces Extension of Letter of Intent
30/03/2018 - 00:51 -
DiaMedica Therapeutics Announces Final Closing of Private Placement
30/03/2018 - 00:08 -
K2M Names Lane Major Chief Operating Officer
29/03/2018 - 22:45 -
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
29/03/2018 - 22:30 -
Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors
29/03/2018 - 22:30 -
Reata Announces That Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan
29/03/2018 - 22:15 -
CohBar, Inc. Announces Closing of First Tranche of Private Placement
29/03/2018 - 22:10 -
resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018 - 22:05 -
Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress
29/03/2018 - 22:05 -
KemPharm Reports Fourth Quarter and Year End 2017 Results
29/03/2018 - 22:05 -
Recro Pharma Announces Commercial Team Additions
29/03/2018 - 22:05 -
Marrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial Results
29/03/2018 - 22:05 -
Spine Injury Solutions Announces Results for the Fiscal Full Year Ended December 31, 2017
29/03/2018 - 22:05 -
IntelGenx Reports Fourth Quarter and Full-Year 2017 Financial Results
29/03/2018 - 22:01 -
CV Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018 - 21:26 -
CORRECTION: FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
29/03/2018 - 19:30 -
TOMI™ Environmental Solutions, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018 - 18:46
Pages